Investor Presentaiton
Radiation has never been more important in cancer care
Underpinned by the shift from radiation "in a box" to radiation "in a shot"
The evolution from external-beam radiation to
systematically-delivered and targeted radiation is
transforming the role of radiation in cancer care
From a 'box'
To a 'shot'
For personal use only
·
•
Synergy between imaging and therapy
Broad cancer utility
Potential to enhance existing drug
classes (androgens, taxanes etc.)
A vitally important "primer" for
immuno-oncology
A future cornerstone modality for
gene/cell therapy conditioning
Telix Pharmaceuticals Limited (ASX: TLX)
く
Telix is driving the integration of nuclear medicine and medical oncology with more
targeted and personalised therapy and patient-friendly dosing regimens
18
TELIX
PHARMACEUTICALSView entire presentation